We believe that this could be in part a consequence of the GC treatment, which may interfere with the relationship between leptin and insulin, as GCs influence the insulin signalling pathway.42 However, other potential factors should also be considered, including hyperandrogenism and insulin or leptin resistance. Here, INS is linked to hyperandrogenism.